HLA Typing Transplant Diagnostic Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
- Transparency Market Research
- In Vitro Diagnostics
HLA typing recognizes the exceptional group of HLA antigens for a person. Identification of HLA-class I and class II antigens is carried out by molecular diagnostic procedures based on DNA. HLA typing utilizing these advanced DNA innovations and provides more vigorous, accurate testing results that are reliable in identifying difference in HLA genes.
Technological developments in HLA typing, increase in number of procedures involving solid organ, stem cell transplantation, and soft tissue transplantation, rise in support in research and development, surge in investment in public private funds are the major factors driving the global HLA typing transplant diagnostics services market. However, unfavorable reimbursement policies for organ transplantation and donation procedures and high cost of polymerase chain reaction-based technological devices hamper the growth of the market. Moreover, shift in technology from serological assays to HLA profiling which is gene based and advancements in health care facilities across emerging countries present significant opportunities for HLA typing transplant players in the market. Significant gap between the number of organ donors and the number of organs that are required annually restrains the global HLA typing transplant diagnostic services market.
Based on technology, the global HLA typing transplant diagnostics services market can be segmented into molecular assay technology [polymerase chain reaction (PCR)], and sequencing based [next-generation sequencing (NGS)] and non-molecular assay technology. The polymerase chain reaction (PCR) segment is projected to dominate the global HLA typing transplant diagnostics services market. However, the next-generation sequencing segment is anticipated to grow at a rapid pace during the forecast period. The polymerase chain reaction segment can be sub-segmented into PCR-SSP (sequence-specific primer), PCR SSOP (sequence-specific oligonucleotide), and PCR-SBT (sequencing based typing). The PCR-SSP sub-segment is expected to dominate the polymerase chain reaction segment. However, the PCR-SBT segment is likely to expand at a high CAGR during the forecast period. In terms of end-user, the global HLA typing transplant diagnostics services market can be classified into hospitals, transplant centers, specialty clinics, and academic institutes. The hospitals segment is expected to dominate the global HLA typing transplant diagnostics services market during the forecast period.
Geographically, the global HLA typing transplant diagnostics services market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Industrially developed nations in Europe and North America such as the U.S. and Canada account for the largest share of the global market owing to rise in prevalence of chronic diseases such as cancer, cardiac, and renal associated diseases. However, increase in access and high adoption of advanced diagnostic technologies, advancements in technologies related to HLA-based transplant diagnostics, and high growth have been witnessed in emerging markets in Asia Pacific. Demand for HLA typing transplant diagnostics services in Asia Pacific is driven by high population growth, increase in awareness, and rise in investments in health care infrastructure. Major players in the market are focusing on this region to compensate for the sluggish business in highly competitive markets in the West. Leading players in the diagnostic services market are acquiring smaller technology companies to produce companion diagnostic services and expand them.
Key players operating in the HLA typing transplant diagnostics services market are One Lambda (Thermo Fischer Scientific, Inc.), Proimmune Ltd., Immucor, Inc., Creative Biolabs, Olerup SSP AB, Histogenetics LLC, QIAGEN, Inc., The UCLA Immunogenetics Center, Affymetrix, Inc., Admera Health, Illumina, Inc., Quick Biology, New York Blood Center, The Sequencing Center, F. Hoffmann-La Roche Ltd., BloodCenter of Wisconsin, and Laboratory Corporation of America Holdings.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from In Vitro Diagnostics
Medical DevicesImpact of Chinas Medical Devices Market-Thematic Research
Medical DevicesGenomics-Thematic Research